You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Boston researchers join international Alzheimer’s mission

Researchers from Boston University School of Medicine are part of an international collaboration, announced today, to discover and map all of the genes linked to Alzheimer's disease in an effort to improve treatments.

The collaboration, which includes groups of scientists from the United States, France, and the United Kingdom, will study detailed files from 40,000 patients, half of whom have been diagnosed with Alzheimer's disease and the rest healthy older adults. The patients come from across Europe, the UK, the United States, and Canada.

Continue reading below

While each group of scientists is currently working with thousands of participants – including people with Alzheimer’s and those free of dementia – scientists in the four groups said that only by working together can they amass a large enough collection of participants to accelerate gene discovery. The collaboration creates a shared resource database that includes genetic data for the more than 40,000 individuals.

A primary goal, the scientists said, is to understand how people may inherit Alzheimer's and whether other factors may play a role.

"We are particularly interested in understanding the relationship between genes we uncover ... and environmental risk factors," one of the local lead researchers, Dr. Sudha Seshadri, of Boston University School of Medicine, said in a statement released by the school.

The group expects to present its first findings at the Alzheimer’s Association International Conference on Alzheimer’s Disease in Paris in July.

Other Boston University researchers involved in the collaboration include Lindsay Farrer, Anita DeStefano, and Drs. Philip Wolf and Stephanie Debette.

The project is being funded by the Alzheimer's Association and the Fondation Plan Alzheimer of France, and includes a two-year, $250,000 grant from the Alzheimer's Association.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.